SBRNA

Serial Number 97709367
731

Registration Progress

Application Filed
Dec 8, 2022
Under Examination
May 7, 2024
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Nov 07, 2025 100 days

Trademark Image

SBRNA

Basic Information

Serial Number
97709367
Filing Date
December 8, 2022
Published for Opposition
March 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Apr 29, 2025
Application
Pending
Classes
001 005 042

Rights Holder

Iris Medicine, Inc.

03
Address
2630 Bancroft Way
Berkeley, CA 94704

Ownership History

Iris Medicine, Inc.

Original Applicant
03
Berkeley, CA

Iris Medicine, Inc.

Owner at Publication
03
Berkeley, CA

Legal Representation

Attorney
Syed Abedi

USPTO Deadlines

Next Deadline
100 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 07, 2025
Extension Available
Until May 07, 2025

Application History

25 events
Date Code Type Description Documents
Apr 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 29, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 29, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 6, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 6, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 6, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 7, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 10, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 10, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 10, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 26, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 26, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Sep 28, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 28, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 28, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 12, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Clinical preparations in the nature of chemicals and biochemicals for use in the manufacture of medical preparations for treatment of genetic diseases
Class 005
Pharmaceutical preparations for the treatment of genetic diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases
Class 042
Development of pharmaceutical preparations and medicines for genetic diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases

Classification

International Classes
001 005 042